REFERENCES
- Verdoux H, Mury M, Besançon G, Bourgeois M. Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders. Encephale. 1996;22:95–101.
- Wobrock T, Soyka M. Pharmacotherapy of schizophrenia with comorbid substance use disorder—reviewing the evidence and clinical recommendations. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:1375–1385.
- Green AI, Noordsy DL, Brunette MF, O’Keefe C. Substance abuse and schizophrenia: pharmacotherapeutic intervention. J Subst Abuse Treat. 2008;34:61–71.
- Kenna GA, Leggio L, Swift RM. A safety and tolerability laboratory study of the combination of aripiprazole and topiramate in volunteers who drink alcohol. Hum Psychopharmacol. 2009;24:465–472.
- Martinotti G, Di Nicola M, Di Giannantonio M, Janiri L. Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. naltrexone. J Psychopharmacol. 2009;23:123–129.
- Kampman KM, Pettinati H, Lynch KG, et al. A pilot trial of topiramate for the treatment of cocaine dependence. Drug Alcohol Depend. 2004;75:233–240.
- Johnson BA, Ait-Daoud N, Akhtar FZ, Javors MA. Use of oral topiramate to promote smoking abstinence among alcohol-dependent smokers. A randomized controlled trial. Arch Intern Med. 2005;165:1600–1605.
- Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep. 1962;10:799–812.
- Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome sale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261–276.
- Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62.
- Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50–55.
- Guy W. ECDEU Assessment Manual for Psychopharmacology. Revised. 1976. DHEW Publication No. ADM 76–338. National Institute of Mental Health: Rockville, MD.
- Calsyn DA, Jason A, Malcy JA, Saxon AJ. Slow tapering from methadone maintenance in a program encouraging indefinite maintenance. J Subst Abuse Treat. 2006;30:159–163.